Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 14 December 2026
- Last conf. stmt
- 30 November 2025
Genea Biomedx UK Limited
- Incorporated
- 30 November 2012 (13 years)
- Previously known as
- Genea Bioplatforms UK Limited (until 7 August 2013)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Ka King Cheng
- Owned by
- Bo LiangGenea Biomedx Pty Ltd
- Accounts type
- Small
- Region
- South East
- Address
- Office 20 Second Floor Innovation HouseRamsgate RoadSandwichCT13 9FF
Charges
- Total
- 4
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 4
Officers 1 active
Officer details are public data from the Companies House register.
Cheng, Ka King
Director · Appointed 18 October 2024
Hong Konger
Born October 1967 (59)
Officer history (9 former)
18 October 2024
Appointed Cheng, Ka King as Director
18 October 2024
Resigned Liang, Bo, Dr as Director
23 June 2023
22 June 2023
Appointed Liang, Bo, Dr as Director
21 June 2023
Resigned Hon, Hoi Kwong as Director
21 June 2023
Resigned Cheng, Ka King as Director
21 June 2023
Resigned Lancken, Bradley Peter as Director
30 September 2022
Appointed Cheng, Ka King as Director
30 September 2022
Appointed Hon, Hoi Kwong as Director
30 September 2022
30 September 2022
Appointed Lancken, Bradley Peter as Director
30 September 2022
Resigned Stojanov, Tomas as Director
30 September 2022
Resigned Graney, Susan Rose as Director
26 February 2016
Resigned Weaver, Mary as Secretary
1 December 2015
Appointed Graney, Susan Rose as Director
26 November 2015
Resigned Brennan, Christopher David as Director
11 February 2015
Appointed Weaver, Mary as Secretary
30 November 2012
Appointed Brennan, Christopher David as Director
30 November 2012
Appointed Stojanov, Tomas as Director
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Bo Liang
Individual · Notified 21 June 2023
Owns 25–50% of shares
Chinese
Born August 1980 (46)
Genea Biomedx Pty Ltd
Corporate entity · Notified 1 September 2022
Owns 75–100% of shares
Proprietary Limited Company
Reg. no. 107 185 651
Former controllers (2)
1 September 2022
Ceased We Doctor Holdings Limited — Owns 50–75% of shares
1 July 2021
Ceased Kam Ching Ng — Owns 25–50% of shares
Financials
Figures from 2023 accounts. Newer accounts, made up to 31 December 2024, are filed but not read yet. See them on Companies House
- Net Assets
- (£6,221,210)
- Cash
- £158,312
- Turnover
- £3,245,659
- Profit Before Tax
- £2,515,232
- Employees
- 5
- Debt Ratio
- 525%
- Current Ratio
- 0.2x
- Profit Margin
- 77%
Trend
Turnover
Balance sheet detail
| 2023 | 2022 | 2021 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £35,174 | £52,220 | £727,019 | £817,863 | £894,294 | £1,094,128 |
| Current Assets | £1,430,239 | £3,084,674 | £5,680,339 | £5,218,501 | £4,876,506 | £4,399,759 |
| Debtors | £619,133 | £893,586 | £2,113,025 | £655,794 | ||
| Cash | £158,312 | £503,205 | £825,472 | £316,365 | £1,090,027 | £204,646 |
| Creditors (< 1 year) | £7,617,389 | £11,804,102 | £14,579,837 | £13,839,834 | £12,723,103 | £11,516,673 |
| Creditors (> 1 year) | £147,500 | £147,500 | ||||
| Net Current Assets | (£6,187,150) | (£8,719,428) | (£8,899,498) | (£8,621,333) | (£7,846,597) | (£7,116,914) |
| Net Assets | (£6,221,210) | (£8,736,442) | (£8,241,713) | (£7,911,401) | (£7,223,503) | (£6,282,736) |
| Shareholder Funds | (£6,221,210) | (£8,736,442) | (£8,241,713) | (£7,911,401) | (£7,223,503) | (£6,282,736) |
| Turnover | £3,245,659 | £6,413,368 | £2,991,264 | £5,074,427 | £5,978,544 | £6,893,356 |
| Cost of Sales | £2,175,717 | £4,655,021 | £2,886,578 | £4,607,278 | £5,386,793 | £6,447,181 |
| Gross Profit | £1,069,942 | £1,758,347 | £104,686 | £467,149 | £591,751 | £446,175 |
| Admin Expenses | £159,520 | £2,258,052 | £476,121 | £1,175,621 | £1,524,857 | £1,295,165 |
| Operating Profit | £887,523 | (£499,705) | (£371,435) | (£708,472) | (£933,106) | (£848,990) |
| Profit Before Tax | £2,515,232 | (£494,785) | (£369,009) | (£703,667) | (£929,014) | (£847,393) |
| Tax | £0 | (£56) | (£38,697) | (£15,769) | £11,753 | £979,110 |
| Profit for Period | £2,515,232 | (£494,729) | (£330,312) | (£687,898) | (£940,767) | (£1,826,503) |
Filings 71
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 29 September 2026 | Accounts for a small company | 31 December 2024 | ||
| 19 January 2026 | Full accounts | 31 December 2023 | ||
| 8 January 2026 | Confirmation statement with updates | 30 November 2025 | ||
| 13 December 2024 | Confirmation statement with no updates | 30 November 2024 | ||
| 18 October 2024 | Termination of appointment of a director |
Other companies in this industry
Cambridge
Coventry
Weybridge
Stevenage
Reading
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →